NCT04900558 is a clinical trial of Radical Cystectomy in Bladder Cancer, sponsored by University of Florence.

Who is sponsoring NCT04900558?

NCT04900558 is sponsored by University of Florence.

What drugs are being tested in NCT04900558?

Interventions in NCT04900558: Radical Cystectomy.

What condition does NCT04900558 study?

NCT04900558 studies Bladder Cancer, Muscle-Invasive Bladder Carcinoma, Oncology, Recurrence, Surgery.

Is NCT04900558 still recruiting?

NCT04900558 is currently recruiting now. Last updated 25 May 2021.

Last reviewed 2021-05-25 · How we verify

NCT04900558

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Robotic Radical Cystectomy Outcomes

Recruiting now Last updated 25 May 2021

What this trial tests

trial testing Radical Cystectomy in Bladder Cancer in 500 participants. Currently enrolling.

Timeline

29 April 2021

Primary endpoint
1 February 2031

1 February 2038

Quick facts

Lead sponsor	University of Florence
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	500
Start date	29 April 2021
Primary completion	1 February 2031
Estimated completion	1 February 2038
Sites	1 location across Italy

Drugs / interventions tested

Radical Cystectomy

Conditions studied

Bladder Cancer — all drugs for Bladder Cancer →
Muscle-Invasive Bladder Carcinoma — all drugs for Muscle-Invasive Bladder Carcinoma →
Oncology — all drugs for Oncology →
Recurrence — all drugs for Recurrence →

Sponsor

University of Florence

Who can join

18 and older, any sex, with Bladder Cancer or Muscle-Invasive Bladder Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Currently, in the treatment of bladder cancer the use of robotics has entered in clinical practice, therefor robotic radical cystectomy with or without reconstruction is offered to patients during counseling procedures, if deemed appropriate and possible. The aim of the study is therefore the long-term evaluation of the peri-post-operative, oncological and functional results of patients undergoing radical cystectomy, both with an open and robotic approach. This study will thus help to clarify the actual impact of robotic surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Radical Cystectomy

Trials testing the same drug.

NCT07332351 — Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle · Phase 2 · not yet recruiting
NCT07202819 — Effect of Neoadjuvant Chemotherapy on MRI Accuracy Before Cystectomy · NA · recruiting
NCT06263153 — Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patie · Phase 2 · recruiting
NCT06091124 — Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma · Phase 2 · recruiting
NCT05581589 — Sacituzumab Govitecan Before Radical Cystectomy for the Treatment of Non-Urothelial Muscle Invasive Bladder Cancer · Phase 2 · recruiting

Other recruiting trials for Bladder Cancer

Currently open trials in the same condition.

NCT07419295 — A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031) · Phase 3 · recruiting
NCT07322263 — Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC · Phase 2 · recruiting
NCT07420517 — Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder Cancer · Phase 2 · recruiting
NCT07475403 — Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer · Phase 2 · recruiting
NCT07277413 — A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors · Phase 1 · recruiting

Other University of Florence trials

Trials by the same sponsor.

NCT06628921 — The Effectiveness of Eptinezumab During a Migraine Attack (the BE-FREE Study) · recruiting
NCT06123000 — Modified Widman Flap vs Fibre Retention Osseous Resective Surgery · NA · recruiting
NCT06135753 — Psychosomatic Intervention in Fibromyalgia. · NA · recruiting
NCT06086821 — Clinical Relevance of Different Time of Periodontal Re-evaluation · NA · completed
NCT06884553 — Robotic Rehabilitation Vs Occupational Therapy Chronic Stroke Upper Limb Rehabilitation · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04900558 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Florence
Last refreshed: 25 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04900558.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing